Journal Article

Genomic profiling of circulating tumor DNA for childhood cancers

Koo, Selene C., Sunny, Jobin, Chang, Ti-Cheng, Ma, Xiaotu, Cheng, Zhongshan, Mead, Paul E., Rubnitz, Jeffrey E., Szlachta, Karol, Wu, Gang, Mullighan, Charles G., Jeha, Sima, Bailey, Colin P., Xu, Ke, Tatevossian, Ruth G., Kumar, Priyadarshini, Gajjar, Amar, Hui, Yawei, Lei, Shaohua, Pui, Ching-Hon, Gao, Qingsong, Takalkar, Sunitha, Robinson, Giles W., Inaba, Hiroto, Pappo, Alberto S., Klco, Jeffery M., Federico, Sara M., Jia, Sujuan

2025

Overview

The utility of circulating tumor DNA (ctDNA) analysis has not been well-established for disease detection and monitoring of childhood cancers, especially leukemias. We developed PeCan-Seq, a deep sequencing method targeting diverse somatic genomic variants in cell-free samples in childhood cancer. Plasma samples were collected at diagnosis from 233 children with hematologic, solid and brain tumors. All children with hematologic malignancy (n = 177) had detectable ctDNA at diagnosis. The median ctDNA fraction was 0.77, and 97% of 789 expected tumor variants were identified, including sequence mutations, copy number variations, and structural variations responsible for oncogenic fusions. In contrast, ctDNA was detected in 19 of 38 solid tumor patients and 1 of 18 brain tumor patients. Somatic variants from ctDNA were correlated with minimal residual disease levels as determined by flow cytometry in serial plasma samples from patients with B-cell acute lymphoblastic leukemia (B-ALL). We showcase multi-tumor detection by ctDNA analysis for a patient with concurrent B-ALL and neuroblastoma. In conclusion, PeCan-seq sensitively identified heterogeneous ctDNA alterations from 1 mL plasma for childhood hematologic malignancies and a subset of solid tumors. PeCan-seq provides a robust, non-invasive approach to augment comprehensive genomic profiling at diagnosis and mutation-specific detection during disease monitoring.

• Publisher: Nature Publishing Group
• Subject: Acute lymphoblastic leukemia / Adolescent / Biomarkers, Tumor - blood / Biomarkers, Tumor - genetics / Blood cancer / Brain / Brain cancer / Brain tumors / Cancer / Child / Child, Preschool / Childhood / Children / Circulating Tumor DNA - blood / Circulating Tumor DNA - genetics / Copy number / Deoxyribonucleic acid / Diagnosis / Disease detection / DNA / DNA Copy Number Variations / DNA fingerprinting / Female / Flow cytometry / Genomic analysis / Genomics / Genomics - methods / Hematologic Neoplasms - blood / Hematologic Neoplasms - genetics / High-Throughput Nucleotide Sequencing - methods / Humans / Infant / Leukemia / Lymphatic leukemia / Lymphocytes B / Male / Minimal residual disease / Monitoring / Mutation / Neoplasm, Residual - genetics / Neoplasms - blood / Neoplasms - diagnosis / Neoplasms - genetics / Solid tumors / Telemedicine / Tumors